Items where Author is "Ledergerber, B."

Article

Matter-Walstra, K. W. and Greiner, M. and Cusini, A. and Schiesser, M. and Ledergerber, B. and Fehr, T. and Mueller, N. J.. (2015) Stringent adherence to a cytomegalovirus-prevention protocol is associated with reduced overall costs in the first 6 months after kidney transplantation. Transplant infectious disease, Vol. 17, H. 3. pp. 342-349.

Cusini, A. and Vernazza, P. L. and Yerly, S. and Decosterd, L. A. and Ledergerber, B. and Fux, C. A. and Rohrbach, J. and Widmer, N. and Hirschel, B. and Gaudenz, R. and Cavassini, M. and Klimkait, T. and Zenger, F. and Gutmann, C. and Opravil, M. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2013) Higher CNS Penetration-Effectiveness of Long-term Combination Antiretroviral Therapy Is Associated With Better HIV-1 Viral Suppression in Cerebrospinal Fluid. JAIDS: journal of acquired immune deficiency syndromes, Vol. 62, H. 1. pp. 28-35.

Scherrer, A. U. and Boni, J. and Yerly, S. and Klimkait, T. and Aubert, V. and Furrer, H. and Calmy, A. and Cavassini, M. and Elzi, L. and Vernazza, P. L. and Bernasconi, E. and Ledergerber, B. and Gunthard, H. F. and Swiss HIV Cohort Study Shcs, . (2012) Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens. PLoS one, Vol. 7, H. 11 , e50307.

Scherrer, A. U. and Ledergerber, B. and von Wyl, V. and Boni, J. and Yerly, S. and Klimkait, T. and Cellerai, C. and Furrer, H. and Calmy, A. and Cavassini, M. and Elzi, L. and Vernazza, P. L. and Bernasconi, E. and Gunthard, H. F. and Swiss HIV Cohort Study Shcs, . (2012) Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients. PLoS one, Vol. 7, H. 6 , e37983.

Thierfelder, C. and Weber, R. and Elzi, L. and Furrer, H. and Cavassini, M. and Calmy, A. and Bernasconi, E. and Gutmann, C. and Ledergerber, B. and Swiss HIV Cohort Study Group, . (2012) Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study. HIV medicine, Vol. 13. pp. 118-126.

Scherrer, A. U. and von Wyl, V. and Gotte, M. and Klimkait, T. and Cellerai, C. and Yerly, S. and Boni, J. and Held, L. and Ledergerber, B. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2012) Polymorphic mutations associated with the emergence of the multinucleoside/tide resistance mutations 69 insertion and Q151M. Journal of acquired immune deficiency syndromes and human retrovirology, Vol. 59, H. 2. pp. 105-112.

Kouyos, R. D. and von Wyl, V. and Yerly, S. and Boni, J. and Rieder, P. and Joos, B. and Taffe, P. and Shah, C. and Burgisser, P. and Klimkait, T. and Weber, R. and Hirschel, B. and Cavassini, M. and Rauch, A. and Battegay, M. and Vernazza, P. L. and Bernasconi, E. and Ledergerber, B. and Bonhoeffer, S. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2011) Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clinical Infectious Diseases, Vol. 52, H. 4. pp. 532-539.

Schüpbach, Jörg and Bisset, Leslie R. and Regenass, Stephan and Bürgisser, Philippe and Gorgievski, Meri and Steffen, Ingrid and Andreutti, Corinne and Martinetti, Gladys and Shah, Cyril and Yerly, Sabine and Klimkait, Thomas and Gebhardt, Martin and Schöni-Affolter, Franziska and Rickenbach, Martin and Swiss HIV Cohort Study, and Barth, J. and Battegay, M. and Bernascon, E. and Böni, J. and Bucher, H. C. and Bürgisser, P. and Burton-Jeangros, C. and Calmy, A. and Cavassini, M. and Dubs, R. and Egger, M. and Elzi, L. and Fehr, J. and Fischer, M. and Flepp, M. and Francioli, P. and Furrer, H. and Fux, C. A. and Gorgievski, M. and Günthard, H. and Hasse, B. and Hirsch, H. H. and Hirschel, B. and Hösli, I. and Kahlert, C. and Kaiser, L. and Keiser, O. and Kind, C. and Klimkait, T. and Kovari, H. and Ledergerber, B. and Martinetti, G. and Martinez de Tejada, B. and Müller, N. and Nadal, D. and Pantaleo, G. and Rauch, A. and Regenass, S. and Rickenbach, M. and Rudin, C. and Schmid, P. and Schultze, D. and Schöni-Affolter, F. and Schüpbach, J. and Speck, R. and Taffé, P. and Telenti, A. and Trkola, A. and Vernazza, P. and von Wyl, V. and Weber, R. and Yerly, S.. (2011) High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease. BMC infectious diseases, Vol. 11 , 254. p. 254.

Scherrer, A. U. and von Wyl, V. and Joos, B. and Klimkait, T. and Burgisser, P. and Yerly, S. and Boni, J. and Ledergerber, B. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2011) Predictors for the emergence of the 2 multi-nucleoside/nucleotide resistance mutations 69 insertion and Q151M and their impact on clinical outcome in the Swiss HIV cohort study. Journal of Infectious Diseases, Vol. 203, no. 6. pp. 791-797.

Ledergerber, B. and Cavassini, M. and Battegay, M. and Bernasconi, E. and Vernazza, P. and Hirschel, B. and Furrer, H. and Rickenbach, M. and Weber, R. and Swiss HIV Cohort Study, . (2011) Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study. HIV medicine, Vol. 12, H. 5. pp. 279-288.

Scherrer, A. U. and von Wyl, V. and Boni, J. and Yerly, S. and Klimkait, T. and Burgisser, P. and Garzoni, C. and Hirschel, B. and Cavassini, M. and Battegay, M. and Vernazza, P. L. and Bernasconi, E. and Ledergerber, B. and Gunthard, H. F. and Swiss HIV Cohort Study Shcs, . (2011) Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors. JAIDS, Vol. 57, H. 1. pp. 24-31.

Kouyos, R. D. and von Wyl, V. and Yerly, S. and Boni, J. and Rieder, P. and Joos, B. and Taffe, P. and Shah, C. and Burgisser, P. and Klimkait, T. and Weber, R. and Hirschel, B. and Cavassini, M. and Rauch, A. and Battegay, M. and Vernazza, P. L. and Bernasconi, E. and Ledergerber, B. and Bonhoeffer, S. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2010) Ambiguity in population-based sequencing of HIV-1 as a marker for the age of HIV infection. Antiviral therapy, Vol. 15 , A158-A158.

Franceschi, S. and Lise, M. and Clifford, G. M. and Rickenbach, M. and Levi, F. and Maspoli, M. and Bouchardy, C. and Dehler, S. and Jundt, G. and Ess, S. and Bordoni, A. and Konzelmann, I. and Frick, H. and Dal Maso, L. and Elzi, L. and Furrer, H. and Calmy, A. and Cavassini, M. and Ledergerber, B. and Keiser, O. and Swiss HIV Cohort Study, . (2010) Changing patterns of cancer incidence in the early- and late-HAART periods : the Swiss HIV Cohort Study. British journal of cancer, Vol. 103, no. 3. pp. 416-422.

Combescure, Christophe and Vallier, N. and Ledergerber, B. and Cavassini, M. and Furrer, H. and Rauch, A. and Battegay, M. and Bernasconi, E. and Vernazza, P. and Hirschel, B.. (2009) How reliable is an undetectable viral load? HIV medicine : the official journal of the British HIV Association (BHIVA) and the European AIDS Clinical Society (EACS), Vol. 10. pp. 470-476.

Scherrer, A. U. and Hasse, B. and von Wyl, V. and Yerly, S. and Böni, J. and Bürgisser, P. and Klimkait, T. and Bucher, H. C. and Ledergerber, B. and Günthard, H. F.. (2009) Prevalence of etravirine mutations and impact on response to treatment in routine clinical care : the Swiss HIV Cohort Study (SHCS). HIV medicine : the official journal of the British HIV Association (BHIVA) and the European AIDS Clinical Society (EACS), Vol. 10. pp. 647-656.

Vo, T. T. and Ledergerber, B. and Keiser, O. and Hirschel, B. and Furrer, H. and Battegay, M. and Cavassini, M. and Bernasconi, E. and Vernazza, P. and Weber, R. and Swiss, HIV Cohort Study. (2008) Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study. Journal of Infectious Diseases, Vol. 197, no. 12. pp. 1685-1694.

von Wyl, V. and Yerly, S. and Böni, J. and Bürgisser, P. and Klimkait, T. and Battegay, M. and Bernasconi, E. and Cavassini, M. and Furrer, H. and Hirschel, B. and Vernazza, P. L. and Rickenbach, M. and Ledergerber, B. and Günthard, H. F. and Swiss, HIV Cohort Study. (2008) Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir. Clinical Infectious Diseases, Vol. 46. pp. 1299-1309.

Weiser, B. and Philpott, S. and Klimkait, T. and Burger, H. and Kitchen, C. and Bürgisser, P. and Gorgievski, M. and Perrin, L. and Piffaretti, J. C. and Ledergerber, B. and Swiss, HIV Cohort Study. (2008) HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy. AIDS, Vol. 22. pp. 469-479.